[{"target":63,"price":21.320,"returns":196,"ticker":"AERI","note":"Avg. Price Target Opinion: Aerie Pharmaceuticals (AERI) likely to achieve $63.11 in 52-week period - Market Seat","to_char":"10/25/2019","q_eps":null,"a_eps":-5.170,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":32,"price":11.000,"returns":192,"ticker":"KALV","note":"Avg. Price Target Opinion: KalVista Pharmaceuticals (KALV) likely to achieve $32.14 in 52-week period - Market Seat","to_char":"10/28/2019","q_eps":null,"a_eps":-1.380,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":32,"price":12.180,"returns":165,"ticker":"MGNX","note":"Price Target Summary: MacroGenics (MGNX) likely to touch $32.3 in 52-week period - Market Seat","to_char":"10/24/2019","q_eps":null,"a_eps":-3.470,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":210,"price":80.240,"returns":162,"ticker":"RETA","note":"Avg. Price Target Opinion: Reata Pharmaceuticals (RETA) likely to achieve $210.75 in 52-week period - Market Seat","to_char":"10/25/2019","q_eps":null,"a_eps":-4.060,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":18,"price":6.940,"returns":159,"ticker":"UIS","note":"Avg. Price Target Opinion: Unisys Corporation (UIS) likely to achieve $18 in 52-week period - Market Seat","to_char":"10/25/2019","q_eps":null,"a_eps":0.740,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null}]
